NCT05874843 Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients
| NCT ID | NCT05874843 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indiana University |
| Condition | Coagulopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 125 participants |
| Start Date | 2023-09-11 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 125 participants in total. It began in 2023-09-11 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the performance of the TEG6s in normal pediatric patients. The main questions it aims to answer are: What are the normal TEG 6S lab results in normal pediatric patients and how do they compare to existing published reference ranges. Participants and their guardians will be asked to submit a small amount of blood at the beginning of an elective operation for analysis in the TEG 6s machine.
Eligibility Criteria
Inclusion Criteria: -Patients less than 18 years of age undergoing elective pediatric surgical care in the operating room at Riley Hospital for Children Exclusion Criteria: * Known disorder of coagulation pathway(s) * Administration of medications that may alter the coagulation cascade * Patients in foster care or wards of the court
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05874843 clinical trial?
This trial is open to participants of all sexes, aged 3 Months or older, up to 18 Years, studying Coagulopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05874843 currently recruiting?
Yes, NCT05874843 is actively recruiting participants. Contact the research team at landman@iu.edu for enrollment information.
Where is the NCT05874843 trial being conducted?
This trial is being conducted at Indianapolis, United States.
Who is sponsoring the NCT05874843 clinical trial?
NCT05874843 is sponsored by Indiana University. The trial plans to enroll 125 participants.